The opioid epidemic in the United States is a public health emergency. Minimally invasive surgical technology has decreased length of hospital stay, improved postoperative recovery, and decreased postoperative pain. Hysterectomy is one of the most commonly performed surgeries in the United States. Increasing trends in minimally invasive gynecologic surgery are expected to reduce patients' postoperative pain. It is unclear whether this assumption has resulted in decreasing postoperative opioid prescriptions or patient need for these prescriptions, as prescribing patterns may be contributing to the current opioid public health emergency. OBJECTIVE: We sought to describe opioid prescribing and patient procurement practices for postoperative pain at time of discharge for benign hysterectomy from 2004 through 2014 using the Truven Health Analytics MarketScan Research Database. The trends of the route of hysterectomy over this time period were concomitantly described to reflect the movement toward more minimally invasive approaches. Opioid prescription procurement has increased despite a concomitant increase in minimally invasive hysterectomy routes. In light of the current opioid epidemic, physicians must recognize that postoperative prescribing practices may contribute to chronic opioid use. Heightened awareness of opioid prescribing practices following surgery is critically important to decrease risk of development of chronic opioid dependence.
Introduction
The United States is in the midst of an opioid epidemic, now classified as a public health emergency. 1 The evolution of opioid prescribing practices involves a complicated history of the Joint Commission and state medical boards' stance on evaluating and treating pain, pharmaceutical companies' influence without adequate evidence, and a movement toward a right to pain relief. 2e5 Currently, the United States leads the world in opioid consumption accounting for 80% of all prescriptions, dispensing 650,000 opioid prescriptions each day. 6, 7 As a result, increased nonmedical opioid use and abuse have led to a rapid increase in death due to opioid-related overdose. Since the year 2000, deaths from drug overdose have increased 137%, including a 200% increase in the rate of overdose deaths involving opioids-approximately 91 deaths each day. 8, 9 The longterm implications of opioid prescribing practices must be investigated in order to have any possibility of achieving meaningful change.
Prescribing opioids for postoperative pain is a widely accepted practice. Historically, opioid-naïve patients were considered immune to long-term opioid use disorder when treated for acute and postoperative pain. However, more evidence suggests that this is not a definite rule. 10e12 In general, characteristics of patients at risk for long-term opioid use disorder, after the initial prescription, include older women, a pain diagnosis prior to opioid initiation, and higher first prescription dosages. 13 After major elective surgeries, approximately 50% of patients are prescribed opioids and 3% of those patients continue to use opioids after their postoperative period. 11 Additional risks of prolonged opioid use have included lower socioeconomic status, chronic medical conditions, drug and alcohol abuse, and use of antidepressants and benzodiazepines preoperatively. 11, 12 Postoperative pain management is often a patient's first experience with opioids, so these risk factors for long-term use are critical for providers to understand.
Hysterectomy is one of the most common gynecologic surgeries performed in the United States.
14e17 While trends in gynecologic surgery aim to reduce patients' postoperative pain, it is unclear whether this has translated into decreased opioid use postoperatively. Given the public health emergency in AJOG at a Glance Why was this study conducted? To describe opioid prescribing and patient procurement practices for postoperative pain at time of discharge for benign hysterectomy from 2004 through 2014 using the Truven Health Analytics MarketScan Research Database.
Key findings
While minimally invasive routes of hysterectomy have increased, the percentage of patients filling opioid prescriptions and the mean days supplied increased as well.
What does this add to what is known?
This study calls attention to gynecologists regarding opioid prescribing practices and patient procurement of opioid prescriptions over time. This adds to the growing literature regarding opioid use to understand our current status as a public health emergency. ajog.org opioid abuse, it is incumbent upon providers to evaluate how opioids are prescribed postoperatively. Therefore, the primary aim of this study was to describe trends in postoperative opioid prescribing practices as well as patient procurement of postoperative opioids after discharge for benign hysterectomy in the United States from 2004 through 2014. Given the background of increases in opioid use and abuse, we decided to explore the possibility that despite the increase in minimally invasive routes of hysterectomy over time, the amount of opioids prescribed or filled at the time of discharge have not decreased. 30, 2014 . We excluded hysterectomies performed for malignancy or associated with an obstetrical delivery by excluding key words such as "radical hysterectomy," "cesarean hysterectomy," and "lymph node dissection." The postoperative pain management for oncologic patients and procedures coincident with pregnancy and delivery were considered inherently different than routine indications to represent a more homogenous cohort. Furthermore, we assumed that missing values were missing completely at random or missing at random and hence we omitted all cases with missing values from the analysis.
Materials and Methods
Hysterectomy type was categorized into abdominal, laparoscopic, and vaginal. These categories were used to reflect the most invasive approach by incision type. Robotic hysterectomies were categorized as "laparoscopic." "Other" hysterectomy was excluded from the analysis because this accounted for only 0.5% of the hysterectomy types and no further descriptive details regarding route or concomitant procedures were available for interpretation. If an encounter included >1 hysterectomy code, the most invasive approach was assigned as the category, so each hysterectomy was only accounted for once, to maintain mutually exclusive groups. The investigators assigned the order of invasiveness from least to most invasive as follows: vaginal (least invasive) laparoscopic (intermediately invasive) to abdominal (most invasive). For example, if an encounter included both vaginal and laparoscopic hysterectomy codes, the encounter was categorized as laparoscopic.
Demographics included patient age, year of surgery, insurance type, length of hospital stay, US region, and preoperative history of opioid use. Patient age was categorized into the following groups: 20e40, 41e60, and >61 years old. Length of hospital stay was defined with day 0 as the date of hysterectomy until date of discharge. If a patient was discharged home at the same day of surgery, 
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ajog.org the length of hospital stay was 0. Insurance type was described as either Medicare or commercial insurance based on the MarketScan database source. US regions were divided into northeast, south, midwest, and west as defined by the US census. 19 A preoperative history of opioid use was defined as prescriptions for opioids that were given within 12 months prior to time of hysterectomy.
Additionally, the postoperative period was defined as 90 days after discharge from the hospital. The opioids quantified in the postoperative period represented outpatient prescriptions filled following discharge. The MarketScan database only captures prescriptions filled at a retail or mail-order pharmacy and does not capture prescriptions filled within the inpatient, hospital facility. Inpatient opioid use was not included in the postoperative opioid use. Pharmacy claims data include the fill date, quantity supplied, and number of days supplied. Days supplied was used to reflect the total amount of opioids prescribed and filled by the patient as described in previous studies using the MarketScan database for opioid practice patterns. 12, 20, 21 Mean days supplied is used instead of oral morphine equivalents, because of the study design to consolidate the opioid filled by ingredient, which did not consider the dosage. Of note, additional prescriptions may have been written by physicians postoperatively, but the database only reflects those that were filled by the patient.
Descriptive statistics were used to summarize demographic data within the entire study period. Preoperative chronic opioid use was a dichotomous variable. Although this article is purely descriptive, further analyses were conducted for exploratory purposes only. For example, analysis of variance was used to compare the means of !3 groups with respect to continuous variables while c 2 testing was used to examine associations between categorical variables. Multiple linear regression was used to describe associations between variables of interest and postoperative opioid prescriptions over time. We used the Breusch-Pagan test for heteroscedasticity to validate the constant variance assumption of the linear regression modeling while relaxing the normality assumption. Specifically, due to the large sample size of the used data, we used 100 random subsets of 5000 observations to conduct Breusch-Pagan test as recommended for other assumption tests. when all patients in the database were analyzed including those patients who did not fill any prescription. The increase in mean days of opioid supplied for each route of hysterectomy showed the same trend over time (ie, the same increase in postoperative days supplied was observed for vaginal, laparoscopic, abdominal hysterectomy) (Figure 4 ). All US regions showed the same trend for postoperative opioid prescription patterns; however, the northeast region significantly filled the least opioids over time. The year 2014 represents the greatest regional prescribing differences for mean days supplied among all patients: northeast 9.8 days (95% CI, 9.3e10.2), south 11.7 days (95% CI, 11.4e11.9), midwest 12.1 days (95% CI, 11.7e12.0), and west 12.5 days (95% CI, 12.1e13.0).
When patients who did not fill prescriptions for opioids were excluded the increase in mean day supply remained significant but with a less dramatic rise, from 11.7 days (95% CI, 11.4e12.0) to 14.0 days (95% CI, 13.9e14.2), an increase of D ¼ 2.3 days (P < .001). prescribed and filled their opioid prescriptions. The mean days of opioids supplied changed from 12.0 days (95% CI, 11.6e12.3) to 15.6 days (95% CI, 15.2e16.0) for abdominal hysterectomy, from 11.5 days (95% CI, 10.9e12.2) to 13.5 days (95% CI, 13.3e13.7) for laparoscopic hysterectomy, and from 11.0 days (95% CI, 10.4e11.6) to 13.4 days (95% CI, 12.9e14.0) for vaginal hysterectomy (all P values <.05).
Patients with a history of preoperative opioid use were compared to opioidnaïve patients. Of patients, 36% had a history of preoperative opioid use. The mean days of opioids supplied postoperatively from 2004 through 2014 increased for both groups over time. The patients with a history of preoperative opioid use consistently filled more opioids during the postoperative period. Patients who were not prescribed and/or did not fill their postoperative opioid prescriptions were then excluded to assess mean days supplied over time. Figure 6 describes patients with a history of preoperative opioid use, opioid-naïve patients, and the overall trend of mean days supplied from 2004 through 2014 among all hysterectomy routes for only those women who filled postoperative opioids. The patients with a history of preoperative opioid use still consistently received more opioids from 18.9 days (95% CI, 18.1e19.6) to 19.3 days (95% CI, 18.9e19.6) compared to opioidnaïve patients who were prescribed and filled 8.5 days (95% CI, 8.3e8.7) to 8.8 days (95% CI, 8.7e9.0) with a P value <.001.
Linear regression was used to examine the association between length of hospital stay and postoperative opioid prescriptions filled. For each additional day in the hospital, an additional 0.44 day of opioid supply was prescribed and filled during the postoperative period (P < .001). The constant variance assumption for this model was achieved according to the Breusch-Pagan test for heteroscedasticity (87 out of 100 samples of the size of 5000 yielded a P value that is >.05). Correlation was drawn between mean days supplied and minimally invasive route (vaginal and laparoscopic approaches) over time where mean days supplied was consistently the highest for abdominal hysterectomy. Patients who had abdominal hysterectomies filled prescriptions with significantly more opioids than laparoscopic and vaginal hysterectomy (P < .05). However, no statistical significant difference was appreciated among minimally invasive routes (laparoscopic vs vaginal hysterectomies). When adjusting for year and length of stay, there was no significant association between mean days supplied among minimally invasive and abdominal hysterectomies (P ¼ .14).
Comment
From 2004 through 2014, the route of hysterectomy increased among minimally invasive routes such as laparoscopic and vaginal approaches. Despite this trend toward minimally invasive surgery, postoperative opioid prescriptions filled by patients appears to have increased. Furthermore, associations related to increased opioid prescriptions filled included patient age, length of hospital stay, and opioid use preoperatively. Every US region showed the same trend in change of route of hysterectomy, but the northeast demonstrated less opioid prescriptions filled postoperatively for all hysterectomy routes. The trend of postoperative opioid prescriptions after hysterectomy reflects the overall increase in opioid prescriptions filled in the United States. However, this increase was most pronounced between the years 2008 through 2011. When patients who were not prescribed and/or filled their opioid prescriptions were excluded, the mean days supplied for all hysterectomy routes increased from 2004 through 2014 and remained statistically significant. In summary, more patients are filling their opioid prescriptions postoperatively along with a slight increase in mean days supplied.
In 2004, approximately 25% of patients filled a prescription for opioids for postoperative pain after hysterectomy. This appears surprisingly low especially since abdominal hysterectomies were more common during that year. Other research in opioid prescribing trends among other surgical specialties show similar trends. Brat et al 26 utilized the Aetna health and pharmacy insurance 26 Results from other surgical procedures report that in the years later than those included in this study (2012 through 2017), greater than two thirds of patients filled their opioid prescriptions after discharge. 27, 28 These results provide external validation to the MarketScan data and highlight the trends in increased patient procurement of opioids over time for postoperative pain.
Research in postoperative opioid use has drastically increased since the medical community and public at large have recognized the severe implications of long-term opioid use and the increase in nonmedical abuse. Medical providers are trapped in a unique paradoxproviding adequate pain control without excessively prescribing opioids. While guidelines are available for treatment of chronic pain, limited information exists for management of acute postoperative pain. Without guidance for acute postoperative pain prescriptions, practice patterns vary widely. A retrospective study of common, outpatient general surgery procedures showed 70e100% of patients are prescribed opioids. The number of pills prescribed varied by providers up to 120 pills with variance among individual providers performing the same surgery. 29 Additionally, most patients do not use the entire prescription given, 29e31 leaving excess opioid pills unused and increasing the opportunity for nonmedical use later. The excessive prescriptions are a problem as most nonmedical users obtain the medications from friends or family for free. 9 Inpatient opioid use may predict postoperative prescription needs. Hill et al, 32 in 2017, described a postoperative prescription guideline based on the opioids used 24 hours prior to discharge. Using their guidelines, postoperative opioid prescriptions decreased by 40%. 32 More surgical subspecialties need to evaluate postoperative prescription patterns to avoid unnecessary opioid exposure contributing to the epidemic.
Hysterectomy is one of the most common surgeries performed in the Mean days of opioids prescribed for patients overall, with preoperative opioid use, and opioid-naϊve patients Mean days of opioids prescribed for patients overall, patients with preoperative opioid use, and opioid-naïve patients. Excluding patients who were not prescribed and/or did not fill their opioid prescriptions. United States with roughly 600,000 hysterectomies performed annually for benign indications. Therefore, women are uniquely at risk for exposure to opioid use and the potential for abuse. Older women have higher rates of longterm opioid use compared to younger women and men of any age. 33 From 1999 through 2010, opioid overdose deaths increased drastically for women by 415%. 34 The opioid epidemic is a national and statewide concern as well as a women's health issue, and prescribing practices after gynecologic surgery needs a closer look. To improve postoperative pain among other factors, minimally invasive techniques are preferred for the route of hysterectomy. Minimally invasive techniques decrease length of hospital stay, decrease postoperative pain, and offer a faster return to normal activity. 35 Therefore, opioid prescribing practices should reflect the current movement toward minimally invasive surgery.
The route of hysterectomy trends over time confirm previously published results. Wu et al, 17 in 2007, reported 538,722 hysterectomies performed in 2003 for benign indications. These were categorized by abdominal (66.1%), laparoscopic (11.8%), and vaginal (21.8%). The hysterectomy rate among US regions showed similar results with the southern region being the highest. 17 The overall decline of hysterectomies performed in the United States is also consistent with other published data. 15 This trend is most likely due to utilization of uterine-sparing surgical options, such as endometrial ablation, and long-acting hormonal contraceptives. 15 The limitations of this study include the inherent limitations to using an administrative claims database. The information available relies on consistent data input to the MarketScan system. The earlier data from 2004 through 2010 have a lower denominator, which in turn, may skew the results due to variability in the sample size over time. Opioid mean days supplied was used to describe the total amount of opioids instead of oral morphine equivalents used in other studies, however, mean days supplied is a common metric utilized in other MarketScan opioid research. 12, 20, 21 An important limitation is that the days supplied represents only prescriptions that were filled at a retail or mail-order pharmacy. This may account for the low percentage of opioids prescribed and/or filled in 2004. If patients received opioids from the inpatient or hospital pharmacies to take home, these prescriptions would not be accounted for in the database. However, data suggest the majority of patients during this time period used nonhospital pharmacies or retail pharmacies to fill their prescriptions. Hospitals offering a discharge prescription service has increased from 11.8% in 2012 to 34.6% in 2016. 36 During our data-reporting period from 2004 through 2014, less than a third of hospitals had a discharge prescription service. 36 If this service was more widely available for patients, we would have expected the number of prescriptions filled overtime to decrease as the utilization of inpatient pharmacies increased, which was not observed. We also cannot account for prescriptions that may have been written but not filled by the patient. The dramatic increase in the percentage of opioid prescriptions filled may be more of a reflection of patient procurement instead of physician prescribing practices. However, if providers are writing even more opioid prescriptions that are not filled, this would only serve to strengthen the findings of this research.
Another limitation is the lack of more robust demographic data. Data on patient race, ethnicity, socioeconomic status, and education are not captured in the Truven databases, and body mass index measures that would normally be recorded as laboratory tests results were also not available, so these factors could not be included. Also, the link between inpatient opioid use and postoperative complications with discharge opioid use were not analyzed due to the study design. These factors may play important roles in postoperative prescribing practices and offer an opportunity for further research. The strengths of this study include the large numbers, and robust data set with data from a recent time frame available with this database. Additionally, we were able to provide regional prescription pattern information across the United States and to assess different routes of hysterectomy while taking into account the increase in minimally invasive techniques over this time period.
The medical profession has a responsibility to focus efforts in improving opioid prescribing practices. A focus on patient education preoperatively is also necessary to manage expectations, and provide necessary information regarding the implications of opioid use. 
